US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 3.1700
  • -0.1200-3.65%
Close Apr 25 16:00 ET
  • 3.1700
  • 0.00000.00%
Post 16:00 ET
81.16MMarket Cap-796P/E (TTM)

About Leap Therapeutics Company

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Company Profile

SymbolLPTX
Company NameLeap Therapeutics
Listing DateJan 24, 2017
Founded2011
CEOMr. Douglas E. Onsi
MarketNASDAQ
Employees54
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address47 Thorndike Street,Suite B1-1
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-714-0360
Websitehttp://www.leaptx.com

Company Executives

  • Name
  • Position
  • Salary
  • Douglas E. Onsi
  • Director, Chief Executive Officer, Chief Financial Officer, President, Treasurer and Secretary
  • 1.88M
  • Cynthia Sirard
  • Chief Medical Officer
  • 1.36M
  • Jason Baum
  • Chief Scientific Officer
  • --
  • Mark O’Mahony
  • Chief Manufacturing Officer
  • --
  • Augustine J. Lawlor
  • Chief Operating Officer
  • 1.36M
  • Christine Granfield
  • Vice President and Head of Regulatory Affairs and Quality
  • --
  • Dr. Christopher K. Mirabelli, PhD
  • Chairman of the Board
  • 678.61K
  • Patricia Martin
  • Director
  • --
  • Christian Richard
  • Director
  • --
  • Dr. James H. Cavanaugh,PhD
  • Independent Director
  • 162.80K
  • Dr. Richard Schilsky, M.D.
  • Independent Director
  • 134.81K
  • Dr. Joseph Loscalzo
  • Independent Director
  • 148.30K
  • Dr. William W. Li, M.D.
  • Independent Director
  • 157.80K
  • Nissim Mashiach
  • Independent Director
  • 152.80K
  • Dr. Thomas J. Dietz, PhD
  • Lead Independent Director
  • 210.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg